Biochemical Recurrence of Prostate Cancer Presenting as Solitary Testicular Metastasis on 68Ga-Labeled Prostate-Specific Membrane Antigen Ligand Positron Emission Tomography/Computed Tomography

2018 ◽  
Vol 43 (9) ◽  
pp. 696-697 ◽  
Author(s):  
Gul Ege Aktas ◽  
Vuslat Yürüt Çaloğlu ◽  
Hakan Akdere ◽  
Busem Binboğa Tutuğ ◽  
Gülay Durmuş Altun
2017 ◽  
Vol 1 ◽  
pp. 3
Author(s):  
Irene A. Chidothe ◽  
David B. Anderson

Biochemical failure after radical treatment for prostate cancer occurs in up to 30% – 50% of cases. Localisation of clinical disease is challenging because clinical symptoms often manifest long after the initial rise in prostate-specific antigen. The detection rates of imaging modalities such as contrasted computed tomography (CT), bone scan, magnetic resonance imaging and choline positron-emission tomography (PET) or CT, are limited. Prostate-specific membrane antigen (PSMA) ligand PET or CT is a novel imaging modality under investigation for various diagnostic and therapeutic indications in the management of prostate cancer. We present a case report illustrating how <sup><span style="font-size: small;">68</span></sup>Gallium-PSMA ligand PET or CT was used to guide management in a patient presenting with biochemical failure after radical prostatectomy.


Sign in / Sign up

Export Citation Format

Share Document